Hurlow Wealth Management Group, Inc. Eli Lilly & CO Transaction History

Hurlow Wealth Management Group, Inc.

$319 Million
Q3 2024

A detailed history of Hurlow Wealth Management Group, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Hurlow Wealth Management Group, Inc. holds 6,242 shares of LLY stock, worth $4.92 Million. This represents 1.74% of its overall portfolio holdings.

Number of Shares

6,242

Previous 6,135 1.74%

Holding current value

$4.92 Million

Previous $5.55 Million 0.43%

% of portfolio

1.74%

Previous 1.91%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 07, 2024	BUY	$772.14 - $960.02 $82,618 - $102,722	107 Added 1.74%	6,242 $5.53 Million
Q2 2024 Jul 12, 2024	BUY	$724.87 - $909.04 $144,974 - $181,808	200 Added 3.37%	6,135 $5.55 Million
Q1 2024 Apr 15, 2024	BUY	$592.2 - $792.28 $5,922 - $7,922	10 Added 0.17%	5,935 $4.62 Million
Q4 2023 Jan 08, 2024	BUY	$525.19 - $619.13 $83,505 - $98,441	159 Added 2.76%	5,925 $3.45 Million
Q3 2023 Oct 10, 2023	SELL	$434.7 - $599.3 $8,694 - $11,986	-20 Reduced 0.35%	5,766 $3.1 Million
Q2 2023 Jul 11, 2023	BUY	$350.74 - $468.98 $2,805 - $3,751	8 Added 0.14%	5,786 $2.71 Million
Q1 2023 Apr 11, 2023	SELL	$310.63 - $364.82 $2,174 - $2,553	-7 Reduced 0.12%	5,778 $1.98 Million
Q4 2022 Jan 18, 2023	SELL	$321.55 - $374.67 $283,928 - $330,833	-883 Reduced 13.24%	5,785 $0
Q1 2022 Apr 13, 2022	SELL	$234.69 - $291.66 $73,457 - $91,289	-313 Reduced 4.48%	6,668 $1.91 Million
Q4 2021 Feb 02, 2022	BUY	$224.85 - $279.04 $67,455 - $83,712	300 Added 4.49%	6,981 $1.45 Million
Q2 2021 Jul 22, 2021	SELL	$180.55 - $233.54 $54,165 - $70,062	-300 Reduced 4.3%	6,681 $1.53 Million
Q1 2021 Apr 20, 2021	SELL	$164.32 - $212.72 $6,572 - $8,508	-40 Reduced 0.57%	6,981 $1.3 Million
Q3 2020 Oct 27, 2020	SELL	$146.22 - $169.13 $17,546 - $20,295	-120 Reduced 1.68%	7,021 $1.04 Million
Q2 2020 Jul 15, 2020	BUY	$136.42 - $164.18 $2,728 - $3,283	20 Added 0.28%	7,141 $1.16 Million
Q1 2020 Apr 16, 2020	SELL	$119.05 - $147.35 $4,762 - $5,894	-40 Reduced 0.56%	7,121 $1.08 Million
Q4 2019 Jan 17, 2020	SELL	$106.92 - $132.43 $534 - $662	-5 Reduced 0.07%	7,161 $1.01 Million
Q2 2019 Jul 18, 2019	SELL	$110.79 - $129.32 $1,772 - $2,069	-16 Reduced 0.22%	7,166 $784,000
Q4 2018 Feb 01, 2019	BUY	$105.9 - $118.64 $760,573 - $852,072	7,182 New	7,182 $826,000

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $749B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hurlow Wealth Management Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hurlow Wealth Management Group, Inc. with notifications on news.

Account

Hurlow Wealth Management Group, Inc. Eli Lilly & CO Transaction History